Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cancer Survival Analysis01:21

Cancer Survival Analysis

493
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
493
Assumptions of Survival Analysis01:15

Assumptions of Survival Analysis

228
Survival models analyze the time until one or more events occur, such as death in biological organisms or failure in mechanical systems. These models are widely used across fields like medicine, biology, engineering, and public health to study time-to-event phenomena. To ensure accurate results, survival analysis relies on key assumptions and careful study design.
228
Introduction To Survival Analysis01:18

Introduction To Survival Analysis

467
Survival analysis is a statistical method used to study time-to-event data, where the "event" might represent outcomes like death, disease relapse, system failure, or recovery. A unique feature of survival data is censoring, which occurs when the event of interest has not been observed for some individuals during the study period. This requires specialized techniques to handle incomplete data effectively.
The primary goal of survival analysis is to estimate survival time—the time...
467
Comparing the Survival Analysis of Two or More Groups01:20

Comparing the Survival Analysis of Two or More Groups

376
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
376
Parametric Survival Analysis: Weibull and Exponential Methods01:14

Parametric Survival Analysis: Weibull and Exponential Methods

774
Parametric survival analysis models survival data by assuming a specific probability distribution for the time until an event occurs. The Weibull and exponential distributions are two of the most commonly used methods in this context, due to their versatility and relatively straightforward application.
Weibull Distribution
The Weibull distribution is a flexible model used in parametric survival analysis. It can handle both increasing and decreasing hazard rates, depending on its shape parameter...
774
Kaplan-Meier Approach01:24

Kaplan-Meier Approach

346
The Kaplan-Meier estimator is a non-parametric method used to estimate the survival function from time-to-event data. In medical research, it is frequently employed to measure the proportion of patients surviving for a certain period after treatment. This estimator is fundamental in analyzing time-to-event data, making it indispensable in clinical trials, epidemiological studies, and reliability engineering. By estimating survival probabilities, researchers can evaluate treatment effectiveness,...
346

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

BiGKbhb: a bi-directional gated recurrent unit model for predicting lysine β-hydroxybutyrylation sites.

BMC genomics·2026
Same author

A deep learning framework for lysine 2-hydroxyisobutyrylation site prediction using evolutionary feature representation.

Scientific reports·2025
Same author

An efficient machine-learning framework for predicting protein post-translational modification sites.

Scientific reports·2025
Same author

Automated classification of urine biomarkers to diagnose pancreatic cancer using 1-D convolutional neural networks.

Journal of biological engineering·2023
Same author

RN-Autoencoder: Reduced Noise Autoencoder for classifying imbalanced cancer genomic data.

Journal of biological engineering·2023
Same author

An ensemble-based drug-target interaction prediction approach using multiple feature information with data balancing.

Journal of biological engineering·2022

Related Experiment Video

Updated: Nov 5, 2025

Author Spotlight: Advancing Alzheimer's Research – Exploring Early Detection and Multi-Omics Approaches
09:47

Author Spotlight: Advancing Alzheimer's Research – Exploring Early Detection and Multi-Omics Approaches

Published on: December 15, 2023

1.4K

A novel deep autoencoder based survival analysis approach for microarray dataset.

Hanaa Torkey1, Mostafa Atlam1, Nawal El-Fishawy1

  • 1Computer Science & Engineering Department, Faculty of Electronic Engineering, Menoufia University, Menouf, Egypt.

Peerj. Computer Science
|May 13, 2021
PubMed
Summary
This summary is machine-generated.

This study introduces a novel autoencoder approach for breast cancer survival analysis, significantly improving prediction accuracy and speed. The method effectively reduces high-dimensional RNA-seq data, identifying key survival-related genes.

Keywords:
Cox regressionRNAseq dataAutoencoderBreast cancerDeep learningGraphical processing unitSurvival analysis

More Related Videos

Performing Data Mining And Integrative Analysis Of Biomarker in Breast Cancer Using Multiple Publicly Accessible Databases
07:41

Performing Data Mining And Integrative Analysis Of Biomarker in Breast Cancer Using Multiple Publicly Accessible Databases

Published on: May 17, 2019

9.2K
Author Spotlight: Impact of Intergenic Interactions on Disease-Identifying Dark Biomarkers
03:37

Author Spotlight: Impact of Intergenic Interactions on Disease-Identifying Dark Biomarkers

Published on: March 1, 2024

1.0K

Related Experiment Videos

Last Updated: Nov 5, 2025

Author Spotlight: Advancing Alzheimer's Research – Exploring Early Detection and Multi-Omics Approaches
09:47

Author Spotlight: Advancing Alzheimer's Research – Exploring Early Detection and Multi-Omics Approaches

Published on: December 15, 2023

1.4K
Performing Data Mining And Integrative Analysis Of Biomarker in Breast Cancer Using Multiple Publicly Accessible Databases
07:41

Performing Data Mining And Integrative Analysis Of Biomarker in Breast Cancer Using Multiple Publicly Accessible Databases

Published on: May 17, 2019

9.2K
Author Spotlight: Impact of Intergenic Interactions on Disease-Identifying Dark Biomarkers
03:37

Author Spotlight: Impact of Intergenic Interactions on Disease-Identifying Dark Biomarkers

Published on: March 1, 2024

1.0K

Area of Science:

  • Bioinformatics and Computational Biology
  • Genomics and Transcriptomics
  • Machine Learning in Healthcare

Background:

  • Breast cancer poses a significant global mortality challenge.
  • Existing survival analysis methods struggle with high-dimensional RNA-seq data.
  • Machine learning (ML) offers potential for improved breast cancer diagnosis and survival prediction.

Purpose of the Study:

  • To develop a novel autoencoder-based approach for feature reduction in high-dimensional RNA-seq data for breast cancer survival analysis.
  • To enhance the accuracy and efficiency of survival prediction models.
  • To identify key genes and biological pathways associated with breast cancer survival.

Main Methods:

  • Utilized an autoencoder for feature reconstruction, noise removal, and extraction of high-variance features from RNA-seq data.
  • Applied Graphical Processing Units (GPUs) to accelerate the autoencoder model training.
  • Estimated patient survival probabilities using Random Survival Forests and Cox regression.
  • Discovered survival-related genes and analyzed their associated biological pathways and molecular functions.

Main Results:

  • The proposed AutoCox and AutoRandom algorithms demonstrated superior concordance index compared to existing deep learning methods.
  • Identified key survival-related genes, including experimentally validated ones like PTPRG, MYST1, BG683264, and AK094562.
  • The autoencoder approach significantly reduced processing time and improved prediction accuracy for survival analysis.
  • Achieved enhanced survival prediction with a reduced error rate.

Conclusions:

  • The novel autoencoder-based feature selection method effectively addresses the challenges of high-dimensional RNA-seq data in breast cancer survival analysis.
  • The approach enhances computational efficiency and predictive accuracy, facilitating the discovery of critical survival-associated genes.
  • This work provides a powerful tool for advancing breast cancer research and clinical decision-making through improved survival prediction.